You are here: Home About Evox Scientific Advisory Board Scientific Advisory Board A core component of Evox’s strategy is to support and drive scientific exploration within the exosome space, with a relentless focus on translating scientific discoveries into patient benefits. To this end, Evox has established an extensive network of scientific advisors and collaborators globally. Professor Matthew Wood Oxford University Professor of Neuroscience and Deputy Head of the Medical Sciences Division at Oxford University and directs the Laboratory of RNA Biology and Neuromuscular Disease. Dr Samir El Andaloussi Karolinska Institutet Associate Professor in Biomolecular Medicine at Karolinska Institutet. His research is focused on exosome-based vehicles for macromolecular drug delivery. Professor Xandra Breakefield Harvard Medical School Professor of Neurology Harvard Medical School. Geneticist, Neurology and Radiology, Massachusetts General Hospital. She conducts research on exosome diagnostics and therapeutics. Dr. Bernd Giebel University of Essen Professor of Regenerative Medicine at the University of Essen. He brings to the Scientific Advisory Board Clinical experience of MSC-derived exosome treatment of GvHD patients. Professor Anastasia Khvorova University of Massachusetts. Professor of Molecular Medicine RNA Therapeutics Institute, University of Massachusetts. She is an expert in RNA therapeutics and performs extensive research on exosomes. Professor Robert Langer Massachusetts Institute of Technology Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology. He is one of the world's leading scientists and advises Evox on brain and CNS delivery. Dr. Pieter Vader University Medical Centre Utrecht Assistant Professor, Department of Clinical Chemistry and Haematology at the University Medical Centre Utrecht. His research is focused on delivery of protein and RNA drugs and has an expertise in exosome engineering.